Figure 1 | Scientific Reports

Figure 1

From: Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells

Figure 1

Schematic summary of the study. (a) MSC-derived MVs are a promising therapeutic tool, with several advantages over current MSC-therapies and soluble biomolecular medications. (b) 3D MSC-culture can address the technical challenges facing conventional culture methods to obtain sufficient amounts of MSC-derived MVs for research and clinical use. (c) Scalable production of therapeutic MSC-derived MVs can be achieved by the simple and effectual 3D MSC-bioprocessing method presented in this study.

Back to article page